Ferroptosis response segregates small cell lung cancer (SCLC) neuroendocrine subtypes

被引:104
作者
Bebber, Christina M. [1 ,2 ,3 ]
Thomas, Emily S. [1 ,2 ,4 ]
Stroh, Jenny [1 ,2 ]
Chen, Zhiyi [1 ,2 ]
Androulidaki, Ariadne [1 ,2 ]
Schmitt, Anna [2 ,3 ]
Hoehne, Michaela N. [2 ,5 ]
Stueker, Lukas [1 ,2 ]
Alves, Cleidson de Padua [1 ]
Khonsari, Armin [1 ,6 ,7 ]
Dammert, Marcel A. [1 ,6 ,7 ]
Parmaksiz, Fatma [1 ,6 ,7 ]
Tumbrink, Hannah L. [1 ,6 ,7 ]
Beleggia, Filippo [3 ]
Sos, Martin L. [1 ,6 ,7 ]
Riemer, Jan [2 ,5 ]
George, Julie [1 ]
Brodesser, Susanne [2 ]
Thomas, Roman K. [1 ,6 ,8 ]
Reinhardt, H. Christian [9 ,10 ]
von Karstedt, Silvia [1 ,2 ,7 ]
机构
[1] Univ Cologne, Fac Med, Dept Translat Genom, Cologne, Germany
[2] Univ Cologne, CECAD Cluster Excellence, Cologne, Germany
[3] Univ Hosp Cologne, Fac Med, Clin Internal Med, Cologne, Germany
[4] Imperial Coll London, London, England
[5] Univ Cologne, Inst Biochem, Dept Chem, Cologne, Germany
[6] Univ Hosp Cologne, Fac Med, Inst Pathol, Cologne, Germany
[7] Univ Hosp Cologne, Ctr Mol Med Cologne, Fac Med, Cologne, Germany
[8] German Canc Consortium DKTK, German Canc Res Ctr, Heidelberg, Germany
[9] Univ Hosp Essen, Dept Hematol & Stem Cell Transplantat, Essen, Germany
[10] Univ Duisburg Essen, German Canc Consortium DKTK partner site Essen, Essen, Germany
关键词
MIXED LINEAGE KINASE; LIPID-METABOLISM; DOMAIN-LIKE; IDENTIFICATION; DEATH; TRAIL; INACTIVATION; GLUTATHIONE; EXPRESSION; CASPASE-8;
D O I
10.1038/s41467-021-22336-4
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Loss of TP53 and RB1 in treatment-naive small cell lung cancer (SCLC) suggests selective pressure to inactivate cell death pathways prior to therapy. Yet, which of these pathways remain available in treatment-naive SCLC is unknown. Here, through systemic analysis of cell death pathway availability in treatment-naive SCLC, we identify non-neuroendocrine (NE) SCLC to be vulnerable to ferroptosis through subtype-specific lipidome remodeling. While NE SCLC is ferroptosis resistant, it acquires selective addiction to the TRX anti-oxidant pathway. In experimental settings of non-NE/NE intratumoral heterogeneity, non-NE or NE populations are selectively depleted by ferroptosis or TRX pathway inhibition, respectively. Preventing subtype plasticity observed under single pathway targeting, combined treatment kills established non-NE and NE tumors in xenografts, genetically engineered mouse models of SCLC and patient-derived cells, and identifies a patient subset with drastically improved overall survival. These findings reveal cell death pathway mining as a means to identify rational combination therapies for SCLC. The high degree of subtype plasticity in small cell lung cancer (SCLC) poses a therapeutic challenge. Here, the authors show that the non-neuroendocrine (non-NE) subtype of SCLC is sensitive to ferroptosis while the neuroendocrine (NE) subtype is vulnerable to TRX anti-oxidant pathway inhibition, and the combination of these two treatments in SCLC circumvents non-NE/NE subtype plasticity.
引用
收藏
页数:19
相关论文
共 86 条
[1]   Signatures of mutational processes in human cancer [J].
Alexandrov, Ludmil B. ;
Nik-Zainal, Serena ;
Wedge, David C. ;
Aparicio, Samuel A. J. R. ;
Behjati, Sam ;
Biankin, Andrew V. ;
Bignell, Graham R. ;
Bolli, Niccolo ;
Borg, Ake ;
Borresen-Dale, Anne-Lise ;
Boyault, Sandrine ;
Burkhardt, Birgit ;
Butler, Adam P. ;
Caldas, Carlos ;
Davies, Helen R. ;
Desmedt, Christine ;
Eils, Roland ;
Eyfjord, Jorunn Erla ;
Foekens, John A. ;
Greaves, Mel ;
Hosoda, Fumie ;
Hutter, Barbara ;
Ilicic, Tomislav ;
Imbeaud, Sandrine ;
Imielinsk, Marcin ;
Jaeger, Natalie ;
Jones, David T. W. ;
Jones, David ;
Knappskog, Stian ;
Kool, Marcel ;
Lakhani, Sunil R. ;
Lopez-Otin, Carlos ;
Martin, Sancha ;
Munshi, Nikhil C. ;
Nakamura, Hiromi ;
Northcott, Paul A. ;
Pajic, Marina ;
Papaemmanuil, Elli ;
Paradiso, Angelo ;
Pearson, John V. ;
Puente, Xose S. ;
Raine, Keiran ;
Ramakrishna, Manasa ;
Richardson, Andrea L. ;
Richter, Julia ;
Rosenstiel, Philip ;
Schlesner, Matthias ;
Schumacher, Ton N. ;
Span, Paul N. ;
Teague, Jon W. .
NATURE, 2013, 500 (7463) :415-+
[2]   Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice [J].
Angeli, Jose Pedro Friedmann ;
Schneider, Manuela ;
Proneth, Bettina ;
Tyurina, Yulia Y. ;
Tyurin, Vladimir A. ;
Hammond, Victoria J. ;
Herbach, Nadja ;
Aichler, Michaela ;
Walch, Axel ;
Eggenhofer, Elke ;
Basavarajappa, Devaraj ;
Radmark, Olof ;
Kobayashi, Sho ;
Seibt, Tobias ;
Beck, Heike ;
Neff, Frauke ;
Esposito, Irene ;
Wanke, Ruediger ;
Foerster, Heidi ;
Yefremova, Olena ;
Heinrichmeyer, Marc ;
Bornkamm, Georg W. ;
Geissler, Edward K. ;
Thomas, Stephen B. ;
Stockwell, Brent R. ;
O'Donnell, Valerie B. ;
Kagan, Valerian E. ;
Schick, Joel A. ;
Conrad, Marcus .
NATURE CELL BIOLOGY, 2014, 16 (12) :1180-U120
[3]   Nivolumab alone and nivolumab plus ipilimumab in recurrent small-cell lung cancer (CheckMate 032): a multicentre, open-label, phase 1/2 trial [J].
Antonia, Scott J. ;
Lopez-Martin, Jose A. ;
Bendell, Johanna ;
Ott, Patrick A. ;
Taylor, Matthew ;
Eder, Joseph Paul ;
Jaeger, Dirk ;
Pietanza, M. Catherine ;
Le, Dung T. ;
de Braud, Filippo ;
Morse, Michael A. ;
Ascierto, Paolo A. ;
Horn, Leora ;
Amin, Asim ;
Pillai, Rathi N. ;
Evans, Jeffry ;
Chau, Ian ;
Bono, Petri ;
Atmaca, Akin ;
Sharma, Padmanee ;
Harbison, Christopher T. ;
Lin, Chen-Sheng ;
Christensen, Olaf ;
Calvo, Emiliano .
LANCET ONCOLOGY, 2016, 17 (07) :883-895
[4]   Cysteine depletion induces pancreatic tumor ferroptosis in mice [J].
Badgley, Michael A. ;
Kremer, Daniel M. ;
Maurer, H. Carlo ;
DelGiorno, Kathleen E. ;
Lee, Ho-Joon ;
Purohit, Vinee ;
Sagalovskiy, Irina R. ;
Ma, Alice ;
Kapilian, Jonathan ;
Firl, Christina E. M. ;
Decker, Amanda R. ;
Sastra, Steve A. ;
Palermo, Carmine F. ;
Andrade, Leonardo R. ;
Sajjakulnukit, Peter ;
Zhang, Li ;
Tolstyka, Zachary P. ;
Hirschhorn, Tal ;
Lamb, Candice ;
Liu, Tong ;
Gu, Wei ;
Seeley, E. Scott ;
Stone, Everett ;
Georgiou, George ;
Manor, Uri ;
Iuga, Alina ;
Wahl, Geoffrey M. ;
Stockwell, Brent R. ;
Lyssiotis, Costas A. ;
Olive, Kenneth P. .
SCIENCE, 2020, 368 (6486) :85-+
[5]   Ferroptosis in Cancer Cell Biology [J].
Bebber, Christina M. ;
Mueller, Fabienne ;
Clemente, Laura Prieto ;
Weber, Josephine ;
von Karstedt, Silvia .
CANCERS, 2020, 12 (01)
[6]   TRAIL-induced survival and proliferation of SCLC cells is mediated by ERK and dependent on TRAIL-R2/DR5 expression in the absence of caspase-8 [J].
Belyanskaya, Larisa L. ;
Ziogas, Algirdas ;
Ns-Donaldson, Sally Hopki ;
Kurtz, Stefanie ;
Simon, Hans-Uwe ;
Stahel, Rolf ;
Zangemeister-Wittke, Uwe .
LUNG CANCER, 2008, 60 (03) :355-365
[7]   The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis [J].
Bersuker, Kirill ;
Hendricks, Joseph M. ;
Li, Zhipeng ;
Magtanong, Leslie ;
Ford, Breanna ;
Tang, Peter H. ;
Roberts, Melissa A. ;
Tong, Bingqi ;
Maimone, Thomas J. ;
Zoncu, Roberto ;
Bassik, Michael C. ;
Nomura, Daniel K. ;
Dixon, Scott J. ;
Olzmann, James A. .
NATURE, 2019, 575 (7784) :688-+
[8]   A Functional Role for Tumor Cell Heterogeneity in a Mouse Model of Small Cell Lung Cancer [J].
Calbo, Joaquim ;
van Montfort, Erwin ;
Proost, Natalie ;
van Drunen, Ellen ;
Beverloo, H. Berna ;
Meuwissen, Ralph ;
Berns, Anton .
CANCER CELL, 2011, 19 (02) :244-256
[9]   Protein expression of TTF1 and cMYC define distinct molecular subgroups of small cell lung cancer with unique vulnerabilities to aurora kinase inhibition, DLL3 targeting, and other targeted therapies [J].
Cardnell, Robert J. ;
Li, Lerong ;
Sen, Triparna ;
Bara, Rasha ;
Tong, Pan ;
Fujimoto, Junya ;
Ireland, Abbie S. ;
Guthrie, Matthew R. ;
Bheddah, Sheila ;
Banerjee, Upasana ;
Kalu, Nene N. ;
Fan, You-Hong ;
Dylla, Scott J. ;
Johnson, Faye M. ;
Wistuba, Ignacio I. ;
Oliver, Trudy G. ;
Heymach, John V. ;
Glisson, Bonnie S. ;
Wang, Jing ;
Byers, Lauren A. .
ONCOTARGET, 2017, 8 (43) :73419-73432
[10]   MYC-Driven Small-Cell Lung Cancer is Metabolically Distinct and Vulnerable to Arginine Depletion [J].
Chalishazar, Milind D. ;
Wait, Sarah J. ;
Huang, Fang ;
Ireland, Abbie S. ;
Mukhopadhyay, Anandaroop ;
Lee, Younjee ;
Schuman, Sophia S. ;
Guthrie, Matthew R. ;
Berrett, Kristofer C. ;
Vahrenkamp, Jeffery M. ;
Hu, Zeping ;
Kudla, Marek ;
Modzelewska, Katarzyna ;
Wang, Guoying ;
Ingolia, Nicholas T. ;
Gertz, Jason ;
Lum, David H. ;
Cosulich, Sabina C. ;
Bomalaski, John S. ;
DeBerardinis, Ralph J. ;
Oliver, Trudy G. .
CLINICAL CANCER RESEARCH, 2019, 25 (16) :5107-5121